These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23587534)

  • 1. [Increase in the incidence of invasive pneumococcal disease caused by serotype 19A prior to the implementation of the expanded pneumococcal vaccines].
    González Martínez F; Saavedra Lozano J; Navarro Gómez ML; Santos Sebastián MM; Rodríguez Fernández R; González Sánchez M; Hernández-Sampelayo Matos T
    An Pediatr (Barc); 2013 Nov; 79(5):288-92. PubMed ID: 23587534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Emergence of invasive pneumococcal disease caused by non-vaccine serotypes in the era of the 7-valent conjugate vaccine].
    González Martínez F; Navarro Gómez ML; Saavedra Lozano J; Santos Sebastián MM; Rodríguez Fernández R; González Sanchéz M; Cercenado Mansilla E; Hernández-Sampelayo Matos T
    An Pediatr (Barc); 2014 Mar; 80(3):173-80. PubMed ID: 23796611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
    Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK; Shea KM; Stevenson AE; Pelton SI;
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
    Pai R; Moore MR; Pilishvili T; Gertz RE; Whitney CG; Beall B;
    J Infect Dis; 2005 Dec; 192(11):1988-95. PubMed ID: 16267772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.
    Yildirim I; Stevenson A; Hsu KK; Pelton SI
    Pediatr Infect Dis J; 2012 Oct; 31(10):1016-21. PubMed ID: 22673142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
    Pilishvili T; Lexau C; Farley MM; Hadler J; Harrison LH; Bennett NM; Reingold A; Thomas A; Schaffner W; Craig AS; Smith PJ; Beall BW; Whitney CG; Moore MR;
    J Infect Dis; 2010 Jan; 201(1):32-41. PubMed ID: 19947881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance.
    Lee MR; Chen CM; Chuang TY; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2013 Nov; 42(5):395-402. PubMed ID: 24071028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.
    Hsieh YC; Lin PY; Chiu CH; Huang YC; Chang KY; Liao CH; Chiu NC; Chuang YC; Chen PY; Chang SC; Liu JW; Yen MY; Wang JH; Liu CY; Lin TY
    Vaccine; 2009 Sep; 27(40):5513-8. PubMed ID: 19615960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
    Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation of invasive pneumococcal disease in Spain in the era of heptavalent conjugate vaccine.
    de Sevilla MF; García-García JJ; Esteva C; Moraga F; Hernández S; Selva L; Coll F; Ciruela P; Planes AM; Codina G; Salleras L; Jordan I; Domínguez A; Muñoz-Almagro C
    Pediatr Infect Dis J; 2012 Feb; 31(2):124-8. PubMed ID: 22173137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona.
    Muñoz-Almagro C; Esteva C; de Sevilla MF; Selva L; Gene A; Pallares R
    J Infect; 2009 Aug; 59(2):75-82. PubMed ID: 19576637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of invasive pneumococcal disease caused by serotype 19A and non-19A pneumococci in children: more empyema in serotype 19A invasive pneumococcal disease.
    Lai CY; Huang LM; Lee PY; Lu CY; Shao PL; Chang LY
    J Microbiol Immunol Infect; 2014 Feb; 47(1):23-7. PubMed ID: 23040234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National surveillance of invasive pneumococcal diseases in Taiwan, 2008-2012: differential temporal emergence of serotype 19A.
    Chiang CS; Chen YY; Jiang SF; Liu DP; Kao PH; Teng HJ; Kuo TL; Yao SM; Tseng LR; Wang YL; Wu HS; Chang FY; Lin TY
    Vaccine; 2014 Jun; 32(27):3345-9. PubMed ID: 24793950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
    Moore MR; Gertz RE; Woodbury RL; Barkocy-Gallagher GA; Schaffner W; Lexau C; Gershman K; Reingold A; Farley M; Harrison LH; Hadler JL; Bennett NM; Thomas AR; McGee L; Pilishvili T; Brueggemann AB; Whitney CG; Jorgensen JH; Beall B
    J Infect Dis; 2008 Apr; 197(7):1016-27. PubMed ID: 18419539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.